カテゴリー： LP Information, 世界, 医療/バイオ

高度免疫グロブリン注射のグローバル市場予測2023-2029

◆英語タイトル：Global Hyperimmune Globulin Injection Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23OT8967）◆商品コード：LP23OT8967
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年10月
◆ページ数：103
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「高度免疫グロブリン注射のグローバル市場」は、過去の販売実績から2022年の世界の高度免疫グロブリン注射の総販売量を検討し、2023年から2029年の予測される高度免疫グロブリン注射の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の高度免疫グロブリン注射の市場規模を掲載し、XXX百万米ドル規模の世界の高度免疫グロブリン注射市場の詳細な分析を提供します。本インサイトレポートは、世界の高度免疫グロブリン注射業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の高度免疫グロブリン注射市場における各社の独自のポジションをより深く理解するために、高度免疫グロブリン注射製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の高度免疫グロブリン注射市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。高度免疫グロブリン注射の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。高度免疫グロブリン注射の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。高度免疫グロブリン注射のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

高度免疫グロブリン注射の世界主要メーカーとしては、CSL Behring、 Grifols、 Biotest、 Kedrion、 CBPO、 Emergent (Cangene)、 Kamada、 CNBG、 Hualan Bio、 Shanghai RAAS、 Sichuan Yuanda Shuyang、 ADMA Biologicsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の高度免疫グロブリン注射市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では高度免疫グロブリン注射市場をセグメンテーションし、種類別 (B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他)、用途別 (政府機関、民間企業、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他

・用途別区分：政府機関、民間企業、その他

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の高度免疫グロブリン注射市場の10年間の市場状況・展望は？
・世界および地域別に見た高度免疫グロブリン注射市場成長の要因は何か？
・高度免疫グロブリン注射の市場機会はエンドマーケットの規模によってどのように変化するのか？
・高度免疫グロブリン注射のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：高度免疫グロブリン注射の年間販売量2018-2029、地域別現状・将来分析
・高度免疫グロブリン注射の種類別セグメント：B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他
・高度免疫グロブリン注射の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・高度免疫グロブリン注射の用途別セグメント：政府機関、民間企業、その他
・高度免疫グロブリン注射の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の高度免疫グロブリン注射市場
・企業別のグローバル高度免疫グロブリン注射市場データ：2018-2023年の年間販売量、市場シェア
・企業別の高度免疫グロブリン注射の年間売上：2018-2023年の売上、市場シェア
・企業別の高度免疫グロブリン注射販売価格
・主要企業の高度免疫グロブリン注射生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

高度免疫グロブリン注射の地域別レビュー
・地域別の高度免疫グロブリン注射市場規模2018-2023：年間販売量、売上
・主要国別の高度免疫グロブリン注射市場規模2018-2023：年間販売量、売上
・南北アメリカの高度免疫グロブリン注射販売の成長
・アジア太平洋の高度免疫グロブリン注射販売の成長
・ヨーロッパの高度免疫グロブリン注射販売の成長
・中東・アフリカの高度免疫グロブリン注射販売の成長

南北アメリカ市場
・南北アメリカの国別の高度免疫グロブリン注射販売量、売上（2018-2023）
・南北アメリカの高度免疫グロブリン注射の種類別販売量
・南北アメリカの高度免疫グロブリン注射の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の高度免疫グロブリン注射販売量、売上（2018-2023）
・アジア太平洋の高度免疫グロブリン注射の種類別販売量
・アジア太平洋の高度免疫グロブリン注射の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の高度免疫グロブリン注射販売量、売上（2018-2023）
・ヨーロッパの高度免疫グロブリン注射の種類別販売量
・ヨーロッパの高度免疫グロブリン注射の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の高度免疫グロブリン注射販売量、売上（2018-2023）
・中東・アフリカの高度免疫グロブリン注射の種類別販売量
・中東・アフリカの高度免疫グロブリン注射の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・高度免疫グロブリン注射の製造コスト構造分析
・高度免疫グロブリン注射の製造プロセス分析
・高度免疫グロブリン注射の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・高度免疫グロブリン注射の主要なグローバル販売業者
・高度免疫グロブリン注射の主要なグローバル顧客

地域別の高度免疫グロブリン注射市場予測レビュー
・地域別の高度免疫グロブリン注射市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・高度免疫グロブリン注射の種類別市場規模予測
・高度免疫グロブリン注射の用途別市場規模予測

主要企業分析
CSL Behring、 Grifols、 Biotest、 Kedrion、 CBPO、 Emergent (Cangene)、 Kamada、 CNBG、 Hualan Bio、 Shanghai RAAS、 Sichuan Yuanda Shuyang、 ADMA Biologics
・企業情報
・高度免疫グロブリン注射製品
・高度免疫グロブリン注射販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hyperimmune Globulin Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hyperimmune Globulin Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hyperimmune Globulin Injection by Country/Region, 2018, 2022 & 2029
2.2 Hyperimmune Globulin Injection Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Rho(D) Immunoglobulins
2.2.5 Other
2.3 Hyperimmune Globulin Injection Sales by Type
2.3.1 Global Hyperimmune Globulin Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Hyperimmune Globulin Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hyperimmune Globulin Injection Sale Price by Type (2018-2023)
2.4 Hyperimmune Globulin Injection Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Others
2.5 Hyperimmune Globulin Injection Sales by Application
2.5.1 Global Hyperimmune Globulin Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Hyperimmune Globulin Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hyperimmune Globulin Injection Sale Price by Application (2018-2023)
3 Global Hyperimmune Globulin Injection by Company
3.1 Global Hyperimmune Globulin Injection Breakdown Data by Company
3.1.1 Global Hyperimmune Globulin Injection Annual Sales by Company (2018-2023)
3.1.2 Global Hyperimmune Globulin Injection Sales Market Share by Company (2018-2023)
3.2 Global Hyperimmune Globulin Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Hyperimmune Globulin Injection Revenue by Company (2018-2023)
3.2.2 Global Hyperimmune Globulin Injection Revenue Market Share by Company (2018-2023)
3.3 Global Hyperimmune Globulin Injection Sale Price by Company
3.4 Key Manufacturers Hyperimmune Globulin Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hyperimmune Globulin Injection Product Location Distribution
3.4.2 Players Hyperimmune Globulin Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hyperimmune Globulin Injection by Geographic Region
4.1 World Historic Hyperimmune Globulin Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Hyperimmune Globulin Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hyperimmune Globulin Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hyperimmune Globulin Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Hyperimmune Globulin Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hyperimmune Globulin Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hyperimmune Globulin Injection Sales Growth
4.4 APAC Hyperimmune Globulin Injection Sales Growth
4.5 Europe Hyperimmune Globulin Injection Sales Growth
4.6 Middle East & Africa Hyperimmune Globulin Injection Sales Growth
5 Americas
5.1 Americas Hyperimmune Globulin Injection Sales by Country
5.1.1 Americas Hyperimmune Globulin Injection Sales by Country (2018-2023)
5.1.2 Americas Hyperimmune Globulin Injection Revenue by Country (2018-2023)
5.2 Americas Hyperimmune Globulin Injection Sales by Type
5.3 Americas Hyperimmune Globulin Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hyperimmune Globulin Injection Sales by Region
6.1.1 APAC Hyperimmune Globulin Injection Sales by Region (2018-2023)
6.1.2 APAC Hyperimmune Globulin Injection Revenue by Region (2018-2023)
6.2 APAC Hyperimmune Globulin Injection Sales by Type
6.3 APAC Hyperimmune Globulin Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hyperimmune Globulin Injection by Country
7.1.1 Europe Hyperimmune Globulin Injection Sales by Country (2018-2023)
7.1.2 Europe Hyperimmune Globulin Injection Revenue by Country (2018-2023)
7.2 Europe Hyperimmune Globulin Injection Sales by Type
7.3 Europe Hyperimmune Globulin Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hyperimmune Globulin Injection by Country
8.1.1 Middle East & Africa Hyperimmune Globulin Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hyperimmune Globulin Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Hyperimmune Globulin Injection Sales by Type
8.3 Middle East & Africa Hyperimmune Globulin Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyperimmune Globulin Injection
10.3 Manufacturing Process Analysis of Hyperimmune Globulin Injection
10.4 Industry Chain Structure of Hyperimmune Globulin Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hyperimmune Globulin Injection Distributors
11.3 Hyperimmune Globulin Injection Customer
12 World Forecast Review for Hyperimmune Globulin Injection by Geographic Region
12.1 Global Hyperimmune Globulin Injection Market Size Forecast by Region
12.1.1 Global Hyperimmune Globulin Injection Forecast by Region (2024-2029)
12.1.2 Global Hyperimmune Globulin Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hyperimmune Globulin Injection Forecast by Type
12.7 Global Hyperimmune Globulin Injection Forecast by Application
13 Key Players Analysis
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Hyperimmune Globulin Injection Product Portfolios and Specifications
13.1.3 CSL Behring Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Hyperimmune Globulin Injection Product Portfolios and Specifications
13.2.3 Grifols Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Biotest
13.3.1 Biotest Company Information
13.3.2 Biotest Hyperimmune Globulin Injection Product Portfolios and Specifications
13.3.3 Biotest Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biotest Main Business Overview
13.3.5 Biotest Latest Developments
13.4 Kedrion
13.4.1 Kedrion Company Information
13.4.2 Kedrion Hyperimmune Globulin Injection Product Portfolios and Specifications
13.4.3 Kedrion Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kedrion Main Business Overview
13.4.5 Kedrion Latest Developments
13.5 CBPO
13.5.1 CBPO Company Information
13.5.2 CBPO Hyperimmune Globulin Injection Product Portfolios and Specifications
13.5.3 CBPO Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CBPO Main Business Overview
13.5.5 CBPO Latest Developments
13.6 Emergent (Cangene)
13.6.1 Emergent (Cangene) Company Information
13.6.2 Emergent (Cangene) Hyperimmune Globulin Injection Product Portfolios and Specifications
13.6.3 Emergent (Cangene) Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Emergent (Cangene) Main Business Overview
13.6.5 Emergent (Cangene) Latest Developments
13.7 Kamada
13.7.1 Kamada Company Information
13.7.2 Kamada Hyperimmune Globulin Injection Product Portfolios and Specifications
13.7.3 Kamada Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kamada Main Business Overview
13.7.5 Kamada Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Hyperimmune Globulin Injection Product Portfolios and Specifications
13.8.3 CNBG Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Hualan Bio
13.9.1 Hualan Bio Company Information
13.9.2 Hualan Bio Hyperimmune Globulin Injection Product Portfolios and Specifications
13.9.3 Hualan Bio Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Bio Main Business Overview
13.9.5 Hualan Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Hyperimmune Globulin Injection Product Portfolios and Specifications
13.10.3 Shanghai RAAS Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Portfolios and Specifications
13.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 ADMA Biologics
13.12.1 ADMA Biologics Company Information
13.12.2 ADMA Biologics Hyperimmune Globulin Injection Product Portfolios and Specifications
13.12.3 ADMA Biologics Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ADMA Biologics Main Business Overview
13.12.5 ADMA Biologics Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Hyperimmune Globulin Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hyperimmune Globulin Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hepatitis B Immunoglobulins
Table 4. Major Players of Rabies Immunoglobulins
Table 5. Major Players of Tetanus Immunoglobulins
Table 6. Major Players of Rho(D) Immunoglobulins
Table 7. Major Players of Other
Table 8. Global Hyperimmune Globulin Injection Sales by Type (2018-2023) & (K Units)
Table 9. Global Hyperimmune Globulin Injection Sales Market Share by Type (2018-2023)
Table 10. Global Hyperimmune Globulin Injection Revenue by Type (2018-2023) & ($ million)
Table 11. Global Hyperimmune Globulin Injection Revenue Market Share by Type (2018-2023)
Table 12. Global Hyperimmune Globulin Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Hyperimmune Globulin Injection Sales by Application (2018-2023) & (K Units)
Table 14. Global Hyperimmune Globulin Injection Sales Market Share by Application (2018-2023)
Table 15. Global Hyperimmune Globulin Injection Revenue by Application (2018-2023)
Table 16. Global Hyperimmune Globulin Injection Revenue Market Share by Application (2018-2023)
Table 17. Global Hyperimmune Globulin Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Hyperimmune Globulin Injection Sales by Company (2018-2023) & (K Units)
Table 19. Global Hyperimmune Globulin Injection Sales Market Share by Company (2018-2023)
Table 20. Global Hyperimmune Globulin Injection Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Hyperimmune Globulin Injection Revenue Market Share by Company (2018-2023)
Table 22. Global Hyperimmune Globulin Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Hyperimmune Globulin Injection Producing Area Distribution and Sales Area
Table 24. Players Hyperimmune Globulin Injection Products Offered
Table 25. Hyperimmune Globulin Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Hyperimmune Globulin Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Hyperimmune Globulin Injection Sales Market Share Geographic Region (2018-2023)
Table 30. Global Hyperimmune Globulin Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Hyperimmune Globulin Injection Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Hyperimmune Globulin Injection Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Hyperimmune Globulin Injection Sales Market Share by Country/Region (2018-2023)
Table 34. Global Hyperimmune Globulin Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Hyperimmune Globulin Injection Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Hyperimmune Globulin Injection Sales by Country (2018-2023) & (K Units)
Table 37. Americas Hyperimmune Globulin Injection Sales Market Share by Country (2018-2023)
Table 38. Americas Hyperimmune Globulin Injection Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Hyperimmune Globulin Injection Revenue Market Share by Country (2018-2023)
Table 40. Americas Hyperimmune Globulin Injection Sales by Type (2018-2023) & (K Units)
Table 41. Americas Hyperimmune Globulin Injection Sales by Application (2018-2023) & (K Units)
Table 42. APAC Hyperimmune Globulin Injection Sales by Region (2018-2023) & (K Units)
Table 43. APAC Hyperimmune Globulin Injection Sales Market Share by Region (2018-2023)
Table 44. APAC Hyperimmune Globulin Injection Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Hyperimmune Globulin Injection Revenue Market Share by Region (2018-2023)
Table 46. APAC Hyperimmune Globulin Injection Sales by Type (2018-2023) & (K Units)
Table 47. APAC Hyperimmune Globulin Injection Sales by Application (2018-2023) & (K Units)
Table 48. Europe Hyperimmune Globulin Injection Sales by Country (2018-2023) & (K Units)
Table 49. Europe Hyperimmune Globulin Injection Sales Market Share by Country (2018-2023)
Table 50. Europe Hyperimmune Globulin Injection Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Hyperimmune Globulin Injection Revenue Market Share by Country (2018-2023)
Table 52. Europe Hyperimmune Globulin Injection Sales by Type (2018-2023) & (K Units)
Table 53. Europe Hyperimmune Globulin Injection Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Hyperimmune Globulin Injection Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Hyperimmune Globulin Injection Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Hyperimmune Globulin Injection Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Hyperimmune Globulin Injection Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Hyperimmune Globulin Injection Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Hyperimmune Globulin Injection Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Hyperimmune Globulin Injection
Table 61. Key Market Challenges & Risks of Hyperimmune Globulin Injection
Table 62. Key Industry Trends of Hyperimmune Globulin Injection
Table 63. Hyperimmune Globulin Injection Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Hyperimmune Globulin Injection Distributors List
Table 66. Hyperimmune Globulin Injection Customer List
Table 67. Global Hyperimmune Globulin Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Hyperimmune Globulin Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Hyperimmune Globulin Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Hyperimmune Globulin Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Hyperimmune Globulin Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Hyperimmune Globulin Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Hyperimmune Globulin Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Hyperimmune Globulin Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Hyperimmune Globulin Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Hyperimmune Globulin Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Hyperimmune Globulin Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Hyperimmune Globulin Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Hyperimmune Globulin Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Hyperimmune Globulin Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. CSL Behring Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 82. CSL Behring Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 83. CSL Behring Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. CSL Behring Main Business
Table 85. CSL Behring Latest Developments
Table 86. Grifols Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 87. Grifols Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 88. Grifols Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Grifols Main Business
Table 90. Grifols Latest Developments
Table 91. Biotest Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 92. Biotest Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 93. Biotest Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Biotest Main Business
Table 95. Biotest Latest Developments
Table 96. Kedrion Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 97. Kedrion Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 98. Kedrion Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Kedrion Main Business
Table 100. Kedrion Latest Developments
Table 101. CBPO Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 102. CBPO Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 103. CBPO Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. CBPO Main Business
Table 105. CBPO Latest Developments
Table 106. Emergent (Cangene) Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 107. Emergent (Cangene) Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 108. Emergent (Cangene) Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Emergent (Cangene) Main Business
Table 110. Emergent (Cangene) Latest Developments
Table 111. Kamada Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 112. Kamada Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 113. Kamada Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Kamada Main Business
Table 115. Kamada Latest Developments
Table 116. CNBG Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 117. CNBG Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 118. CNBG Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. CNBG Main Business
Table 120. CNBG Latest Developments
Table 121. Hualan Bio Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 122. Hualan Bio Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 123. Hualan Bio Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Hualan Bio Main Business
Table 125. Hualan Bio Latest Developments
Table 126. Shanghai RAAS Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai RAAS Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 128. Shanghai RAAS Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Shanghai RAAS Main Business
Table 130. Shanghai RAAS Latest Developments
Table 131. Sichuan Yuanda Shuyang Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 132. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 133. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Sichuan Yuanda Shuyang Main Business
Table 135. Sichuan Yuanda Shuyang Latest Developments
Table 136. ADMA Biologics Basic Information, Hyperimmune Globulin Injection Manufacturing Base, Sales Area and Its Competitors
Table 137. ADMA Biologics Hyperimmune Globulin Injection Product Portfolios and Specifications
Table 138. ADMA Biologics Hyperimmune Globulin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. ADMA Biologics Main Business
Table 140. ADMA Biologics Latest Developments
List of Figures
Figure 1. Picture of Hyperimmune Globulin Injection
Figure 2. Hyperimmune Globulin Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hyperimmune Globulin Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hyperimmune Globulin Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hyperimmune Globulin Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hepatitis B Immunoglobulins
Figure 10. Product Picture of Rabies Immunoglobulins
Figure 11. Product Picture of Tetanus Immunoglobulins
Figure 12. Product Picture of Rho(D) Immunoglobulins
Figure 13. Product Picture of Other
Figure 14. Global Hyperimmune Globulin Injection Sales Market Share by Type in 2022
Figure 15. Global Hyperimmune Globulin Injection Revenue Market Share by Type (2018-2023)
Figure 16. Hyperimmune Globulin Injection Consumed in Government Institution
Figure 17. Global Hyperimmune Globulin Injection Market: Government Institution (2018-2023) & (K Units)
Figure 18. Hyperimmune Globulin Injection Consumed in Private Sector
Figure 19. Global Hyperimmune Globulin Injection Market: Private Sector (2018-2023) & (K Units)
Figure 20. Hyperimmune Globulin Injection Consumed in Others
Figure 21. Global Hyperimmune Globulin Injection Market: Others (2018-2023) & (K Units)
Figure 22. Global Hyperimmune Globulin Injection Sales Market Share by Application (2022)
Figure 23. Global Hyperimmune Globulin Injection Revenue Market Share by Application in 2022
Figure 24. Hyperimmune Globulin Injection Sales Market by Company in 2022 (K Units)
Figure 25. Global Hyperimmune Globulin Injection Sales Market Share by Company in 2022
Figure 26. Hyperimmune Globulin Injection Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Hyperimmune Globulin Injection Revenue Market Share by Company in 2022
Figure 28. Global Hyperimmune Globulin Injection Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Hyperimmune Globulin Injection Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Hyperimmune Globulin Injection Sales 2018-2023 (K Units)
Figure 31. Americas Hyperimmune Globulin Injection Revenue 2018-2023 ($ Millions)
Figure 32. APAC Hyperimmune Globulin Injection Sales 2018-2023 (K Units)
Figure 33. APAC Hyperimmune Globulin Injection Revenue 2018-2023 ($ Millions)
Figure 34. Europe Hyperimmune Globulin Injection Sales 2018-2023 (K Units)
Figure 35. Europe Hyperimmune Globulin Injection Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Hyperimmune Globulin Injection Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Hyperimmune Globulin Injection Revenue 2018-2023 ($ Millions)
Figure 38. Americas Hyperimmune Globulin Injection Sales Market Share by Country in 2022
Figure 39. Americas Hyperimmune Globulin Injection Revenue Market Share by Country in 2022
Figure 40. Americas Hyperimmune Globulin Injection Sales Market Share by Type (2018-2023)
Figure 41. Americas Hyperimmune Globulin Injection Sales Market Share by Application (2018-2023)
Figure 42. United States Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Hyperimmune Globulin Injection Sales Market Share by Region in 2022
Figure 47. APAC Hyperimmune Globulin Injection Revenue Market Share by Regions in 2022
Figure 48. APAC Hyperimmune Globulin Injection Sales Market Share by Type (2018-2023)
Figure 49. APAC Hyperimmune Globulin Injection Sales Market Share by Application (2018-2023)
Figure 50. China Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Hyperimmune Globulin Injection Sales Market Share by Country in 2022
Figure 58. Europe Hyperimmune Globulin Injection Revenue Market Share by Country in 2022
Figure 59. Europe Hyperimmune Globulin Injection Sales Market Share by Type (2018-2023)
Figure 60. Europe Hyperimmune Globulin Injection Sales Market Share by Application (2018-2023)
Figure 61. Germany Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Hyperimmune Globulin Injection Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Hyperimmune Globulin Injection Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Hyperimmune Globulin Injection Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Hyperimmune Globulin Injection Sales Market Share by Application (2018-2023)
Figure 70. Egypt Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Hyperimmune Globulin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Hyperimmune Globulin Injection in 2022
Figure 76. Manufacturing Process Analysis of Hyperimmune Globulin Injection
Figure 77. Industry Chain Structure of Hyperimmune Globulin Injection
Figure 78. Channels of Distribution
Figure 79. Global Hyperimmune Globulin Injection Sales Market Forecast by Region (2024-2029)
Figure 80. Global Hyperimmune Globulin Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Hyperimmune Globulin Injection Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Hyperimmune Globulin Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Hyperimmune Globulin Injection Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Hyperimmune Globulin Injection Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 高度免疫グロブリン注射のグローバル市場予測2023-2029(Global Hyperimmune Globulin Injection Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 高度免疫グロブリン製品のグローバル市場予測2023-2029
  • ヒト血漿由来高度免疫製品のグローバル市場予測2023-2029
  • ヒト血漿ベース高度免疫製剤のグローバル市場予測2023-2029
  • 高免疫グロブリンの世界市場予測（〜2030年）

    • ◆H&Iグローバルリサーチのお客様（例）◆